The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications

Curr Radiopharm. 2018;11(3):154-155. doi: 10.2174/187447101103180911115600.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Actinium / chemistry*
  • Actinium / pharmacology*
  • Alpha Particles / therapeutic use*
  • Animals
  • Bismuth / chemistry*
  • Bismuth / pharmacology*
  • Humans
  • Neoplasms / radiotherapy*
  • Radiochemistry / methods*
  • Radioisotopes / chemistry*
  • Radioisotopes / pharmacology*
  • Radionuclide Generators
  • Radiopharmaceuticals / chemical synthesis*
  • Radiopharmaceuticals / pharmacology*

Substances

  • Actinium-225
  • Bismuth-213
  • Radioisotopes
  • Radiopharmaceuticals
  • Actinium
  • Bismuth